SCHEMBL6062899

SCHEMBL6062899

O=C(O)NC[C@H](C(=O)NC1(C(=O)c2nc3ccccc3o2)CCC1)S(=O)(=O)Cc1ccccc1

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
FAAH O00519 3/20 0.37
CES1 P23141 1/20 0.37
DAGLA Q9Y4D2 1/20 0.37
XDH P47989 6/20 0.35
ALDH1A1 P00352 1/20 0.35
KDM4E B2RXH2 2/20 0.34
RAB9A P51151 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
GLO1 Q04760 1/20 0.34
CTSS P25774 2/20 0.34
CHRNA7 P36544 1/20 0.33
POLB P06746 1/20 0.33
NPC1 O15118 1/20 0.33
LMNA P02545 1/20 0.33
MAPT P10636 1/20 0.33
NLRP3 Q96P20 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7042185 0.88 ATM (0.39) FAAHCES1DAGLAXDHALDH1A1
SCHEMBL6063234 0.88 KDM4E (0.37) FAAHCES1DAGLAALDH1A1KDM4E
SCHEMBL6061805 0.86 RAB9A (0.32) XDHKDM4ERAB9AGLO1CTSS
SCHEMBL6462788 0.83 FAAH (0.39) FAAHCES1DAGLAXDHKDM4E
SCHEMBL6062895 0.77 ALDH1A1 (0.42) FAAHCES1DAGLAXDHALDH1A1
SCHEMBL7045494 0.76 EPHX2 (0.39) ALDH1A1CYP2C9CTSS
SCHEMBL7043390 0.76 SCN9A (0.31) CYP3A4
SCHEMBL6468442 0.76 DAGLA (0.55) FAAHCES1DAGLAXDH
SCHEMBL7042180 0.75 MAPT (0.40) ALDH1A1RAB9ACYP3A4CTSSLMNA
SCHEMBL6062346 0.75 CTSS (0.34) ALDH1A1KDM4ERAB9ACTSSNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1694357-A1 USE OF CATHEPSIN S INHIBITORS FOR TREATING AN IMMUNE RESPONSE CAUSED BY ADMINISTRATION OF A SMALL MOLECULE THERAPEUTIC OR BIOLOGIC AXYS PHARMACEUTICALS, INC. (US) 2006-08-30 EP disclosed
WO-2005058348-A1 USE OF CATHEPSIN S INHIBITORS FOR TREATING AN IMMUNE RESPONSE CAUSED BY ADMINISTRATION OF A SMALL MOLECULE THERAPEUTIC OR BIOLOGIC AXYS PHARMACEUTICALS, INC. (US) 2005-06-30 WO disclosed
EP-1516877-A1 Amine derivatives as protease inhibitors AXYS PHARMACEUTICALS, INC. (US) 2005-03-23 EP disclosed